Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a campaign by a patient and a charity. Abiraterone has been provided on the NHS ...

Genitourinary medical oncologist Dr. Michael Morris is part of a new MSK program focused on better treatments for neuroendocrine cancers, which sometimes develop when prostate and lung cancers become ...

DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic ...

The NHS has announced that the drug, abiraterone, will be offered to men with high-risk prostate cancer that has not yet ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...